The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and…
New Delhi, July 22, 2020: Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for domestic market. Bevasizumab biosimilar…
New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…
New Delhi, November 11, 2018: It is difficult to believe that in India, just a decade ago, Cancer was not a commonly…
National, September 06, 2018: A breakthrough study on ‘cancer vaccine approach for personalized treatment of Lynch Syndrome’ by MedGenome was…